Thermo Fisher Scientific Restructuring Charges increased by 30.8% to $34.00M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Frequent or large charges may indicate operational instability or a need for significant strategic pivots, while occasional charges are standard in large-scale transformations.
Restructuring charges are one-time costs associated with reorganizing a company's operations, such as severance pay, fac...
Used by analysts to identify non-recurring items that distort year-over-year operating comparisons.
restructuring_charges| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.00M | $11.00M | $6.00M | $16.00M | $9.00M | $50.00M | $87.00M | $38.00M | $25.00M | $26.00M | $26.00M | $34.00M |
| QoQ Change | — | +22.2% | -45.5% | +166.7% | -43.8% | +455.6% | +74.0% | -56.3% | -34.2% | +4.0% | +0.0% | +30.8% |
| YoY Change | — | — | — | +77.8% | -18.2% | +733.3% | +443.8% | +322.2% | -50.0% | -70.1% | -31.6% | — |